Thyrotropin-releasing hormone and its receptors - A hypothesis for binding and receptor activation

Pharmacology and Therapeutics

Volumn 113, Issue 2, 2007, Pages 410-419

  Engel, Stanislav ^a   Gershengorn, Marvin C ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Active conformation; Agonist; GPCR activation; Ligand binding; Structure activity relationships; TRH receptor

Indexed keywords

CELL SURFACE RECEPTOR; G PROTEIN COUPLED RECEPTOR; PROTIRELIN; PROTIRELIN RECEPTOR;

COMPUTER SIMULATION; LIGAND BINDING; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; STRUCTURE ACTIVITY RELATION;

ANIMALS; BINDING SITES; MODELS, MOLECULAR; PROTEIN CONFORMATION; RECEPTORS, THYROTROPIN-RELEASING HORMONE; THYROTROPIN-RELEASING HORMONE;

EID: 33846428430     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2006.09.004     Document Type: Review

References (41)

1. Buck F., Wang W., Harder S., Brathwaite C., Bruhn T.O., and Gershengorn M.C. Juxtamembrane regions in the third intracellular loop of the thyrotropin-releasing hormone receptor type 1 are important for coupling to Gq. Endocrinology 141 (2000) 3717-3722
2. Chu W., Perlman J.H., Gershengorn M.C., and Moeller K.D. Thyrotropin releasing hormone analogs: A building block approach to the construction of tetracyclic peptidomimetics. Bioorg Med Chem Lett 8 (1998) 3093-3096
3. Colson A.O., Perlman J.H., Jinsi-Parimoo A., Nussenzveig D.R., Osman R., and Gershengorn M.C. A hydrophobic cluster between transmembrane helices 5 and 6 constrains the thyrotropin-releasing hormone receptor in an inactive conformation. Mol Pharmacol 54 (1998) 968-978
4. Colson A.O., Perlman J.H., Smolyar A., Gershengorn M.C., and Osman R. Static and dynamic roles of extracellular loops in G-protein-coupled receptors: a mechanism for sequential binding of thyrotropin-releasing hormone to its receptor. Biophys J 74 (1998) 1087-1100
5. Deslauriers R., Garrigou-Lagrange C., Bellocq A.M., and Smith I.C.P. Carbon-13 nuclear magnetic resonance studies on thyrotropin-releasing factor and related peptides. FEBS Lett 31 (1973) 59-66
6. Dixon R.A., Sigal I.S., Candelore M.R., Register R.B., Scattergood W., Rands E., et al. Structural features required for ligand binding to the beta-adrenergic receptor. EMBO J 6 (1987) 3269-3275
7. Dixon R.A., Sigal I.S., Rands E., Register R.B., Candelore M.R., Blake A.D., et al. Ligand binding to the beta-adrenergic receptor involves its rhodopsin-like core. Nature 326 (1987) 73-77
8. Engel S., Neumann S., Kaur N., Monga V., Jain R., Northup J., et al. Low affinity analogs of thyrotropin-releasing hormone are super-agonists. J Biol Chem 281 (2006) 13103-13109
9. Gershengorn M.C., and Osman R. Minireview: insights into G protein-coupled receptor function using molecular models. Endocrinology 142 (2001) 2-10
10. Han B., and Tashjian Jr. A.H. Identification of Asn289 as a ligand binding site in the rat thyrotropin-releasing hormone (THR) receptor as determined by complementary modifications in the ligand and receptor: a new model for THR binding. Biochemistry 34 (1995) 13412-13422
11. Han B., and Tashjian Jr. A.H. Importance of extracellular domains for ligand binding in the thyrotropin-releasing hormone receptor. Mol Pharmacol 9 (1995) 1708-1719
12. Hinkle P.M., and Kinsella P.A. Rapid temperature-dependent transformation of the thyrotropin-releasing hormone-receptor complex in rat pituitary tumor cells. J Biol Chem 257 (1982) 5462-5470
13. Huang W., Osman R., and Gershengorn M.C. Agonist-induced conformational changes in thyrotropin-releasing hormone receptor type I: disulfide cross-linking and molecular modeling approaches. Biochemistry 44 (2005) 2419-2431
14. Jarv J., and Oras A. Similar dynamics of G-protein coupled receptors molecules in response to antagonist binding. Neurosci Lett 373 (2005) 150-152
15. Kazuhide Kamiya, Masayuki Takamoto, Yoshikazu Wada, Masahiko Fujino, and Masao Nishikawa. Molecular conformation of thyrotropin-releasing hormone from the X-ray structural analysis of its tartrate. J Chem Soc Chem Commun 10 (1980) 438
16. Laakkonen L., Li W., Perlman J.H., Guarnieri F., Osman R., Moeller K.D., et al. Restricted analogues provide evidence of a biologically active conformation of thyrotropin-releasing hormone. Mol Pharmacol 49 (1996) 1092-1096
17. Laakkonen L.J., Guarnieri F., Perlman J.H., Gershengorn M.C., and Osman R. A refined model of the thyrotropin-releasing hormone (TRH) receptor binding pocket. Novel mixed mode Monte Carlo/stochastic dynamics simulations of the complex between TRH and TRH receptor. Biochemistry 35 (1996) 7651-7663
18. Liapakis G., Chan W.C., Papadokostaki M., and Javitch J.A. Synergistic contributions of the functional groups of epinephrine to its affinity and efficacy at the beta2 adrenergic receptor. Mol Pharmacol 65 (2004) 1181-1190
19. Lu X., Huang W., Worthington S., Drabik P., Osman R., and Gershengorn M.C. A model of inverse agonist action at thyrotropin-releasing hormone receptor type 1: role of a conserved tryptophan in helix 6. Mol Pharmacol 66 (2004) 1192-1200
20. MacroModel (2003). (Version 9.1) [Computer software]. Schrodinger, LLC.: New York, NY, USA.
21. Nussenzveig D.R., Heinflink M., and Gershengorn M.C. Decreased levels of internalized thyrotropin-releasing hormone receptors after uncoupling from guanine nucleotide-binding protein and phospholipase-C. Mol Endocrinol 7 (1993) 1105-1111
22. Palanche T., Ilien B., Zoffmann S., Reck M.P., Bucher B., Edelstein S.J., et al. The neurokinin A receptor activates calcium and cAMP responses through distinct conformational states. J Biol Chem 276 (2001) 34853-34861
23. Palczewski K., Kumasaka T., Hori T., Behnke C.A., Motoshima H., Fox B.A., et al. Crystal structure of rhodopsin: A G protein-coupled receptor. Science 289 (2000) 739-745
24. Perlman J.H., Colson A.O., Jain R., Czyzewski B., Cohen L.A., and Osman R. Role of the extracellular loops of the thyrotropin-releasing hormone receptor: evidence for an initial interaction with thyrotropin-releasing hormone. Biochemistry 36 (1997) 15670-15676
25. Perlman J.H., Laakkonen L., Osman R., and Gershengorn M.C. Distinct roles for arginines in transmembrane helices 6 and 7 of the thyrotropin-releasing hormone receptor. Mol Pharmacol 47 (1995) 480-484
26. Perlman J.H., Laakkonen L.J., Guarnieri F., Osman R., and Gershengorn M.C. A refined model of the thyrotropin-releasing hormone (TRH) receptor binding pocket. Experimental analysis and energy minimization of the complex between TRH and TRH receptor. Biochemistry 35 (1996) 7643-7650
27. Perlman J.H., Nussenzveig D.R., Osman R., and Gershengorn M.C. Thyrotropin-releasing hormone binding to the mouse pituitary receptor does not involve ionic interactions. A model for neutral peptide binding to G protein-coupled receptors. J Biol Chem 267 (1992) 24413-24417
28. Perlman J.H., Laakkonen L., Osman R., and Gershengorn M.C. A model of the thyrotropin-releasing hormone (TRH) receptor binding pocket. Evidence for a second direct interaction between transmembrane helix 3 and TRH. J Biol Chem 269 (1994) 23383-23386
29. Perlman J.H., Thaw C.N., Laakkonen L., Bowers C.Y., Osman R., and Gershengorn M.C. Hydrogen bonding interaction of thyrotropin-releasing hormone (TRH) with transmembrane tyrosine 106 of the TRH receptor. J Biol Chem 269 (1994) 1610-1613
30. Phillips W.J., and Cerione R.A. A C-terminal peptide of bovine rhodopsin binds to the transducin alpha-subunit and facilitates its activation. Biochem J 299 Pt 2 (1994) 351-357
31. Rivier J., Vale W., Monahan M., Ling N., and Burgus R. Synthetic thyrotropin-releasing factor analogs. 3. Effect of replacement or modification of histidine residue on biological activity. J Med Chem 15 (2005) 479-4
32. Samama P., Cotecchia S., Costa T., and Lefkowitz R.J. A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model. J Biol Chem 268 (1993) 4625-4636
33. Simpson J.C., Ho C., Berkley Shands E.F., Gershengorn M.C., Marshall G.R., and Moeller K.D. Conformationally restricted TRH analogues: constraining the pyroglutamate region. Bioorg Med Chem 10 (2002) 291-302
34. Stenkamp R.E., Teller D.C., and Palczewski K. Rhodopsin: a structural primer for G-protein coupled receptors. Arch Pharm (Weinheim) 338 (2005) 209-216
35. Sun Y., Lu X., and Gershengorn M.C. Thyrotropin-releasing hormone receptors-similarities and differences. J Mol Endocrinol 30 (2003) 87-97
36. Surgand J.S., Rodrigo J., Kellenberger E., and Rognan D. A chemogenomic analysis of the transmembrane binding cavity of human G-protein-coupled receptors. Proteins 62 (2006) 509-538
37. Swaminath G., Xiang Y., Lee T.W., Steenhuis J., Parnot C., and Kobilka B.K. Sequential binding of agonists to the beta2 adrenoceptor. Kinetic evidence for intermediate conformational states. J Biol Chem 279 (2004) 686-691
38. Tong Y., Olczak J., Zabrocki J., Gershengorn M.C., Marshall G.R., and Moeller K.D. Constrained Peptidomimetics for TRH: cis-Peptide Bond Analogs. Tetrahedron 56 (2000) 9791-9800
39. Vauquelin G., and Van I L. G protein-coupled receptors: a count of 1001 conformations. Fundam Clin Pharmacol 19 (2005) 45-56
40. Vicar J., Abillon E., Toma F., Piriou F., Lintner K., Blaha K., et al. The two conformations of TRH in solution. FEBS Lett 97 (1979) 275-278
41. Zhang W.J., Berglund A., Kao J.L.F., Couty J.P., Gershengorn M.C., and Marshall G.R. Impact of Azaproline on Amide Cis-Trans Isomerism: Conformational Analyses and NMR Studies of Model Peptides Including TRH Analogues. J Am Chem Soc 125 (2003) 1221-1235